Latest News and Press Releases

Company honored with highest award for Central Massachusetts regionNew state-of-the-art Rentschler Biopharma Manufacturing Center (RBMC) facility slated to open for business later this year ...

Exceptional capabilities in guiding therapies from early-stage development through to market based on over 50 years of biotech experience LAUPHEIM, Germany and MILFORD, Mass. and STEVENAGE, United...

Senta Brandt promoted to global position of Head of TransformationGerrick Rodrigues promoted to Global Head of IT LAUPHEIM, Germany and MILFORD, Mass. and STEVENAGE, United Kingdom, Feb. 06, 2024 ...

State-of-the-art Rentschler Biopharma Manufacturing Center (RBMC) facility slated to open for business next year LAUPHEIM, Germany and MILFORD, Mass., Dec. 20, 2023 (GLOBE NEWSWIRE) -- Rentschler...

LAUPHEIM, Germany and MILFORD, Mass. and STEVENAGE, United Kingdom, Dec. 07, 2023 (GLOBE NEWSWIRE) -- Rentschler Biopharma SE, a leading contract development and manufacturing organization (CDMO)...

Benedikt von Braunmuehl, a transformational leader with a 30-year track record in the global healthcare industry, is named CEO Rentschler Biopharma SECompany also announces appointment of Tom Roberts,...

Rentschler Biopharma to conduct adeno-associated virus (AAV) process development work for manufacturing scale-up at their ATMP site in Stevenage, UKIkarovec is developing novel gene therapies to treat...

LAUPHEIM, Germany and MILFORD, Mass., Dec. 07, 2022 (GLOBE NEWSWIRE) -- Rentschler Biopharma, a leading global contract development and manufacturing organization (CDMO) for biopharmaceuticals, is...

Dr. Frank Mathias joined Rentschler Biopharma SE’s Supervisory Board in 2013 and was appointed Chief Executive Officer and Chairman of the Executive Board in April 2016. LAUPHEIM, Germany, Nov. 21,...

Company increases focus on core operationsChristiane Bardroff to head global clinical and commercial manufacturing, engineering and technology operations, as well as production automation LAUPHEIM,...